Publication: Do we need perioperative pharmacogenetic testing?
6
item.page.dc.date.issued
2018-09-01
item.page.dc.type
item.page.dc.identifier.issn
01252208
item.page.dc.identifier.other
2-s2.0-85064225361
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Journal of the Medical Association of Thailand. Vol.101, No.9 (2018), S159-S166
punsarn.item.page.citation
Sirirat Rattana-Arpa, Patcharee Sriswasdi Do we need perioperative pharmacogenetic testing?. Journal of the Medical Association of Thailand. Vol.101, No.9 (2018), S159-S166. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/46340
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Do we need perioperative pharmacogenetic testing?
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
© 2018, Medical Association of Thailand. All rights reserved. Multiple drugs with various mechanisms of actions are used simultaneously during anesthetic practice. Even if the same dose of drug is administered, diverse individual responses usually occur. These different responses might relate to their pharmacogenetics variation. The pharmacogenetics research network has established a pharmacogenetics knowledge base in order to collect, encode, and disseminate knowledge about the impact of human genetic variations on drug response. For perioperative period, opioids are the common drugs used with various individual responses. This review shows the pharmacogenetic aspects of four common opioids: morphine, fentanyl, codeine and oxycodone, and their future trends for perioperative pharmacogenetic testing.
